Form 4 for SUPN SUPERNUS PHARMACEUTICALS, INC.
Accepted 2025-04-03 00:00:00 ET · period of report 2025-04-02 · accession 0001628280-25-016516 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-04-03 | 2025-04-02 | SUPN | Khattar Jack A. | Pres, CEO, Dir | J - Other | — | +16.9K | 1.01M | +2% | — | |
| I | 2025-04-03 | 2025-04-02 | SUPN | Khattar Jack A. | Pres, CEO, Dir | J - Other | — | -16.9K | 1.01M | -2% | — |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-04-02 | J | A | 16,850 | — | 1,008,683 | D By the KBT Trust | — | — | (F1) The Reporting Person is filing this Form 4 to reflect the fact that 16,850 shares were transferred from the KBT Trust to the Reporting Person on April 2, 2025 without consideration and are now owned directly. |
| 2 | Common | Common Stock | 2025-04-02 | J | D | 16,850 | — | 1,005,600 | I | — | — | (F1) The Reporting Person is filing this Form 4 to reflect the fact that 16,850 shares were transferred from the KBT Trust to the Reporting Person on April 2, 2025 without consideration and are now owned directly. |